Crossmark

A randomized, double-blind, placebo-controlled, multicenter study assessing the efficacy of magnesium oxide monohydrate in the treatment of nocturnal leg cramps

Crossref DOI link: https://doi.org/10.1186/s12937-021-00747-9

Published Online: 2021-10-31

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barna, Olha

Lohoida, Pavlo

Holovchenko, Yurii

Bazylevych, Andrii

Velychko, Valentyna

Hovbakh, Iryna

Bula, Larysa

Shechter, Michael http://orcid.org/0000-0002-4193-9917
Funding

Funding for this research was provided by:

Naveh Pharma, Inc., Netanya, Israel (Unrestricted research grant from Naveh Pharma Inc., Netanya, Israel)
License Information

Text and Data Mining valid from 2021-10-31

Version of Record valid from 2021-10-31
More Information

Article History

Received: 20 April 2021

Accepted: 15 October 2021

First Online: 31 October 2021

Declarations

:

: The study protocol, its amendments and the informed consent form were reviewed and approved by Independent Ethics Committees at each site.Subjects provided signed informed consent for participation in this study prior to enrollment.

: Not applicable.

: Authors declare of having no conflict of interest.

Document is current

Any future updates will be listed below